| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/30/2007 | WO2007097358A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 08/30/2007 | WO2007097254A1 Novel isodipeptide |
| 08/30/2007 | WO2007097251A1 PEPTIDE VACCINE FOR INDUCING PRODUCTION OF ANTI-AMYLOID-β-PEPTIDE ANTIBODY |
| 08/30/2007 | WO2007096859A2 Protection of the retina against laser injury by adnf peptides such as nap and sal |
| 08/30/2007 | WO2007096855A2 Angiotensin-i-converting enzyme inhibitory |
| 08/30/2007 | WO2007096662A2 Cancer imaging and treatment |
| 08/30/2007 | WO2007096517A1 Presentation of recognition motifs by a multivalent matrix grafted onto a solid support |
| 08/30/2007 | WO2007096388A1 Polypeptides, pharmaceutical compositions and methods for the prevention and the therapeutic treatment of inflammatory disorders |
| 08/30/2007 | WO2007096182A1 Pcr hot start by magnesium sequestration |
| 08/30/2007 | WO2007079605A3 Template-fixed peptidomimetics with antimicrobial activity |
| 08/30/2007 | WO2007079558A3 Proline-rich peptides, pharmaceutical composition, use of one or more peptides and method of treatment |
| 08/30/2007 | US20070203325 Integrase-dirived HIV-inhibiting agents |
| 08/30/2007 | US20070203071 Conformationally Constrained Parthyroid Hormone (Pth) Analogs |
| 08/30/2007 | US20070203066 Compositions and methods for inhibiting cellular proliferation |
| 08/30/2007 | US20070203057 Compounds and methods for modulating adhesion molecule function |
| 08/30/2007 | US20070202575 Asthma; ellergy vaccine; antisense therapy; used to treat, prevent, or ameliorate the symptoms resulting from exposure to a bio-warfare agent |
| 08/30/2007 | US20070202537 Biomarkers for als |
| 08/30/2007 | US20070202498 comprising at least two chemically different fluorophores, providing a donor and an acceptor respectively, connected together by at least one linker moiety and bonded to a binder moiety; obtaining fluorescence enhancement by energy transfer enabled with binder molecules in diagnostic applications |
| 08/30/2007 | US20070202124 Method for the production of purified invasin protein and use thereof |
| 08/30/2007 | US20070202123 Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids |
| 08/30/2007 | CA2651793A1 Hiv fusion inhibitor peptides with improved biological properties |
| 08/30/2007 | CA2643042A1 Presentation of recognition motifs by a multivalent matrix grafted onto a solid support |
| 08/30/2007 | CA2638827A1 Protection of the retina against laser injury by adnf peptides such as nap and sal |
| 08/30/2007 | CA2638777A1 Novel isodipeptide |
| 08/30/2007 | CA2638775A1 Peptide vaccine for inducing production of anti-amyloid-.beta.-peptide antibody |
| 08/30/2007 | CA2638122A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 08/29/2007 | EP1824976A1 Antimicrobial peptides |
| 08/29/2007 | EP1824498A2 Methods and compositions for treating cellular proliferative diseases |
| 08/29/2007 | EP1254162B1 Kahalalide f and related compounds |
| 08/29/2007 | EP1047301B1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 08/29/2007 | CN101027320A FGFR binding peptides |
| 08/29/2007 | CN101027319A 肝素结合肽 Heparin-binding peptides |
| 08/29/2007 | CN101027316A Tumor targeting agents and uses thereof |
| 08/29/2007 | CN101024672A Novel ring-shape small-peptide BA and its use |
| 08/29/2007 | CN100334106C Synthesis of cyclosporin analogs |
| 08/28/2007 | US7262291 Clostridial toxin derivatives and methods for treating pain |
| 08/28/2007 | US7262282 Fluorescence assay for kinase activity |
| 08/28/2007 | US7262275 Graft polymer of polyester and polypeptide; prevent cyclization |
| 08/28/2007 | US7262271 Immunogens as well as antibodies |
| 08/28/2007 | US7262269 Screening cancer ligands; polypeptide for binding to cancer cells |
| 08/28/2007 | US7262268 Acylating a destryptophan compound to obtain an ornithin amino protected compound, removing the ornithine protecting group; antibiotic daptomycin stereoisomeric compounds |
| 08/28/2007 | US7262169 Process for preparing peptide intermediates |
| 08/28/2007 | US7262163 The peptides exhibit in vitro anti-bacterial properties at concentrations that are not lethal to normal mammalian cells |
| 08/28/2007 | US7261876 Multimeric proteins for use in the treatment and detection of cell proliferative disorders |
| 08/28/2007 | CA2367755C Dimeric compounds and their use as inhibitors of neuraminidase |
| 08/28/2007 | CA1341538C Dna encoding ige receptor alpha-subunit or fragment thereof |
| 08/23/2007 | WO2007094330A1 Peptide capable of activating bombesin-like peptide receptor and use thereof |
| 08/23/2007 | WO2007093839A1 New polypeptides kxk and their use |
| 08/23/2007 | WO2005035003A9 Compositions and methods for increasing drug efficiency |
| 08/23/2007 | US20070197772 Methods for preparing internally constrained peptides and peptidomimetics |
| 08/23/2007 | US20070197446 MHC binding peptides and their uses |
| 08/23/2007 | US20070197445 Neuropeptide Y receptor antagonists and agonists including O-glycosylated tripeptides, O-glycopeptides, and extended tripeptides; cardiovascular disorders; pancreatic polypeptide; peptide yy; pancreatitis; liver disorders |
| 08/23/2007 | US20070197444 Phage displayed cell binding peptides |
| 08/23/2007 | US20070197432 fusion protein comprising an amino acid sequence coupled to a single carrier keyhole limpet hemocyanin (KLH) protein and the bovine serum albumin (BSA) protein; vaccines; veterinary medicine |
| 08/23/2007 | US20070197430 Conjugates And Therapeutic Uses Thereof |
| 08/23/2007 | US20070196900 Method for the manufacture of lantibiotics |
| 08/23/2007 | US20070196448 Enantioselective oligomerization of alpha-hydroxy carboxylic acids and alpha-amino acids |
| 08/23/2007 | US20070196305 Method for identifying hair conditioner-resistant hair-binding peptides and hair benefit agents therefrom |
| 08/22/2007 | EP1820855A1 Anti-histone h1 monoclonal antibody and hybridoma capable of producing the same |
| 08/22/2007 | EP1820805A2 Inhibitor and stimulator of haemotopoietic stem cell proliferation and uses thereof |
| 08/22/2007 | EP1819726A1 Modulation of ovulation |
| 08/22/2007 | EP1819723A2 Drug delivery peptides for crossing blood-brain barrier |
| 08/22/2007 | EP1819722A1 Modulation of ovulation |
| 08/22/2007 | EP1819721A1 Microcin b17 analogs and methods for their preparation and use |
| 08/22/2007 | EP1819346A2 Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases |
| 08/22/2007 | EP1608982B1 Diagnosis of autism |
| 08/22/2007 | EP1572892A4 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 08/22/2007 | EP1157040B1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 08/22/2007 | EP0773950B1 Linked peptide nucleic acids |
| 08/22/2007 | CN1332978C Peptide as antagonist of VEGF receptor Flt-1 |
| 08/22/2007 | CN1332977C Novel techykinin peptides, precursor peptides thereof and genes encoding the same |
| 08/22/2007 | CN1332976C Method of anticipating interaction between proteins |
| 08/22/2007 | CN101020710A Integrase inhibiting peptide and its application in preparing AIDS-treating medicine |
| 08/21/2007 | US7259248 Nucleotide seqqquences coding polypeptide for use in the treatment and prevention of cancer, liver and urogenital disorders |
| 08/21/2007 | US7259236 RBP1L1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof |
| 08/21/2007 | US7259235 Method for generating an immune response and reagents therefor |
| 08/21/2007 | US7259232 Preferred segments of neural thread protein |
| 08/21/2007 | US7259142 Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use |
| 08/21/2007 | US7259137 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases |
| 08/21/2007 | US7259022 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 08/21/2007 | US7258861 Peptides derived from the region of human TNF- alpha from Ser100 to Glu116 to treat pulmonary oedema. |
| 08/21/2007 | CA2257381C Method for producing peptides |
| 08/21/2007 | CA2070004C Cloned glutamic acid decarboxylase |
| 08/16/2007 | WO2007092360A2 Diagnostics and methods for removal and detection of interferents |
| 08/16/2007 | WO2007091959A1 Novel antimicrobial peptides and use thereof |
| 08/16/2007 | WO2007091958A1 Novel antimicrobial peptides and use thereof |
| 08/16/2007 | WO2007091387A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector |
| 08/16/2007 | WO2007090630A2 Peptide aptamer for neutralizing the binding of platelet antigene specific antibodies and diagnostic and therapeutic applications containing the same |
| 08/16/2007 | WO2007090496A1 Synthesis of glucagon-like peptide |
| 08/16/2007 | WO2006069718A9 Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide |
| 08/16/2007 | WO2004060302A3 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 08/16/2007 | WO2002083916A8 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 08/16/2007 | US20070191280 High Purity Lipopeptides |
| 08/16/2007 | US20070190603 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| 08/16/2007 | US20070190561 Nucleotide sequences coding polymerase for use in identifying modulators to treat cell proliferative disorders; enzyme inhibitors; antitumor agents |
| 08/16/2007 | US20070190087 Method for stabilizing oil-based thickening gel composition |
| 08/16/2007 | CA2641053A1 Synthesis of glucagon-like peptide |
| 08/16/2007 | CA2637221A1 Novel antimicrobial peptides and use thereof |
| 08/16/2007 | CA2637216A1 Novel antimicrobial peptides and use thereof |
| 08/15/2007 | EP1818395A1 Compositions and methods for treating lysosomal storage diseases |